Cochrane Summaries

Trusted evidence. Informed decisions. Better health.
Language:
English

Evidence on beneficial or harmful effects of bicyclol for chronic hepatitis C is not found

Yang X, Zhuo Q, Wu T, Liu GJ
Published Online: 
21 January 2009

Bicyclol is a novel synthetic 'anti-hepatitis' drug, used primarily in China for patients with chronic hepatitis C. Only one small, short-term randomised clinical trial was found evaluating the efficacy of bicyclol for patients with chronic hepatitis C. Clinicians should be aware of the lack of evidence for bicyclol.

This record should be cited as: 
Yang X, Zhuo Q, Wu T, Liu GJ. Bicyclol for chronic hepatitis C. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD004994. DOI: 10.1002/14651858.CD004994.pub2
Assessed as up to date: 
3 November 2006